Intervention Protocol

You have free access to this content

Probiotics for fibromyalgia

  1. Vjekoslava Supraha1,*,
  2. Damian K Francis2,
  3. Ana Utrobicic3,
  4. Ernest HS Choy4,
  5. Dana Tenzera5,
  6. Anton Kordic6

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 28 MAR 2013

DOI: 10.1002/14651858.CD010451


How to Cite

Supraha V, Francis DK, Utrobicic A, Choy EHS, Tenzera D, Kordic A. Probiotics for fibromyalgia (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD010451. DOI: 10.1002/14651858.CD010451.

Author Information

  1. 1

    Pharmacy "Pablo", Solin, Croatia

  2. 2

    University of West Indies, Epidemiology Research Unit, Mona Kingston 7, Jamaica

  3. 3

    University of Split, School of Medicine, Central Medical Library, Split, Croatia

  4. 4

    Cardiff University School of Medicine, Section of Rheumatology, Department of Medicine, Cardiff, UK

  5. 5

    "Laboratorij okusa d.o.o.", Development and Production Department, Split, Croatia

  6. 6

    University of Split, School of Medicine, Split, Croatia

*Vjekoslava Supraha, Pharmacy "Pablo", Matoseva 10, Solin, 21210, Croatia. vjeka.supraha@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 28 MAR 2013

SEARCH

References

Additional references

Arnold 2006
Bennett 2005
  • Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clinical and Experimental Rheumatology 2005;23 (Suppl. 39):154-62.
Bernardy 2012
  • Bernardy K, Klose P, Busch AJ, Choy EHS, Häuser W. Cognitive behavioural therapies for fibromyalgia syndrome. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD009796]
Branco 2010
Busch 2007
Choy 2009
  • Choy EH, Arnold LM, Clauw D, Crofford L, Glass JM, Simon L, et al. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. Journal of Rheumatology 2009;36(10):2330-4.
Deare 2009
  • Deare JC, Zheng Z, Xue CC, Liu JP, Shang J, Scott SW, Littlejohn G. Acupuncture for treating fibromyalgia. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD007070]
Derry 2012
Doherty 1995
Durand 1992
  • Durand JM, Kaplanski G, Lefevre P, Richard MA, Andrac L, Trepo C, et al. Effect of interferon-a 2b on cryoglobulinemi a related to hepatitis C virus infection. Journal of Infectious Diseases 1992 Apr;165(4):778-9.
Dworkin 2003
FAO 2001
  • FAO. Health and Nutritional Properties of Probiotics inFood including Powder Milk with Live LacticAcid Bacteria. http://www.fao.org/ 2001 Oct:1-34.
Gabrielli 2009
  • Gabrielli M, Lauritano EC, Scarpellini E, Lupascu A, Ojetti V, Gasbarrini G, et al. Bacillus clausii as a treatment of small intestinal bacterial overgrowth. American Journal of Gastroenterology 2009 May;104(5):1327-8.
Gill 2011
Gupta 2009
Hauser 2010
Hearn 2012
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Vol. [updated March 2011], The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Häuser 2013
  • Häuser W, Urrútia G, Tort S, Üçeyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD010292]
Middleton 1994
Moore 2009
  • Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2]
Moore 2012
Perdigón 1999
  • Perdigón G, Vintiñi E, Alvarez S, Medina M, Medici M. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. Journal of Dairy Science 1999 Jun;82(6):1108-14.
Pimentel 2003
  • Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. American Journal of Gastroenterology 2003 Feb;98(2):412-9.
Pimentel 2004
  • Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Annals of the Rheumatic Diseases 2004 Apr;63(4):450-2.
Preidis 2009
Quigley 2006
Quigley 2007
  • Quigley EM. Bacteria: a new player in gastrointestinal motility disorders: infections, bacterial overgrowth, and probiotics. Gastroenterology Clinics of North America 2007;36:735-48.
Rao 1992
Reid 2003
Review Manager 2011
  • Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Russell 1999
  • Russell IJ, Michalek JE, Kang YK, Richards AB. Reduction of morning stiffness and improvement in physical function in fibromyalgia syndrome patients treated sublingually with low doses of human interferon-alpha. Journal of Interferon and Cytokine Research 1999 Aug;19(8):961-8.
Schiffrin 2009
  • Schiffrin EJ, Parlesak A, Bode C, Bode JC, van't Hof MA, Grathwohl D, et al. Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions. British Journal of Nutrition 2009;101:961-6.
Sperber 1999
  • Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. American Journal of Gastroenterology 1999 Dec;94(12):3541-6.
    Direct Link:
Spiller 2008
Stotzer 1996
  • Stotzer PO, Blomberg L, Conway PL, Henriksson A, Abrahamsson H. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scandinavian Journal of Infectious Diseases 1996;28:615-9.
Theadom 2009
Tort 2012
Triadafilopoulos 1991
Veale 1991
  • Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. British Journal of Rheumatology 1991 Jun;30(3):220-2.
Wolfe 1990
Wolfe 1995
Wolfe 1996